11-72816818-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033388.2(ATG16L2):c.209A>G(p.Gln70Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033388.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251406Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135882
GnomAD4 exome AF: 0.0000958 AC: 140AN: 1461794Hom.: 0 Cov.: 31 AF XY: 0.000100 AC XY: 73AN XY: 727204
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.209A>G (p.Q70R) alteration is located in exon 2 (coding exon 2) of the ATG16L2 gene. This alteration results from a A to G substitution at nucleotide position 209, causing the glutamine (Q) at amino acid position 70 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at